Cargando…

Gene medicine for cancer treatment: Commercially available medicine and accumulated clinical data in China

Loss of p53 function compromises genetic homeostasis, which induces deregulated DNA replication, damages DNA, and subsequently results in increased resistance to anticancer agents. Pharmacological approaches using recombinant adenoviruses (Ad) have been developed to restore the p53 functions. Anothe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Guangyu, Shimada, Hideaki, Hiroshima, Kenzo, Tada, Yuji, Suzuki, Nobuo, Tagawa, Masatoshi
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2761194/ https://www.ncbi.nlm.nih.gov/pubmed/19920899

Ejemplares similares

A Potential Therapeutic Strategy for Malignant Mesothelioma with Gene Medicine
por: Tada, Yuji, et al.
Publicado: (2013)

A Possible Anticancer Agent, Type III Interferon, Activates Cell Death Pathways and Produces Antitumor Effects
por: Tagawa, Masatoshi, et al.
Publicado: (2011)

Midkine is a potential novel marker for malignant mesothelioma with different prognostic and diagnostic values from mesothelin
por: Ak, Guntulu, et al.
Publicado: (2017)

Fas Ligand DNA Enhances a Vaccination Effect by Coadministered DNA Encoding a Tumor Antigen through Augmenting Production of Antibody against the Tumor Antigen
por: Zhong, Boya, et al.
Publicado: (2015)

Mesenchymal stem cells are efficiently transduced with adenoviruses bearing type 35-derived fibers and the transduced cells with the IL-28A gene produces cytotoxicity to lung carcinoma cells co-cultured
por: Suzuki, Takeo, et al.
Publicado: (2014)

An intrapleural administration of zoledronic acid for inoperable malignant mesothelioma patients: a phase I clinical study protocol
por: Tada, Yuji, et al.
Publicado: (2016)

Diffuse pleural thickening and thoracic contraction: An indistinguishable case from malignant pleural mesothelioma
por: Tada, Yuji, et al.
Publicado: (2020)

A clinical protocol to inhibit the HGF/c-Met pathway for malignant mesothelioma with an intrapleural injection of adenoviruses expressing the NK4 gene
por: Tada, Yuji, et al.
Publicado: (2015)

Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways
por: Shimazu, Kengo, et al.
Publicado: (2017)

An MDM2 inhibitor achieves synergistic cytotoxic effects with adenoviruses lacking E1B55kDa gene on mesothelioma with the wild-type p53 through augmenting NFI expression
por: Nguyen, Thao Thi Thanh, et al.
Publicado: (2021)

Combination of a third generation bisphosphonate and replication-competent adenoviruses augments the cytotoxicity on mesothelioma
por: Jiang, Yuanyuan, et al.
Publicado: (2016)

Zoledronic Acid Produces Combinatory Anti-Tumor Effects with Cisplatin on Mesothelioma by Increasing p53 Expression Levels
por: Okamoto, Shinya, et al.
Publicado: (2013)

Cytotoxic effects of replication-competent adenoviruses on human esophageal carcinoma are enhanced by forced p53 expression
por: Yang, Shan, et al.
Publicado: (2015)

Cytotoxicity of replication-competent adenoviruses powered by an exogenous regulatory region is not linearly correlated with the viral infectivity/gene expression or with the E1A-activating ability but is associated with the p53 genotypes
por: Yamauchi, Suguru, et al.
Publicado: (2017)

An image cytometric technique is a concise method to detect adenoviruses and host cell proteins and to monitor the infection and cellular responses induced
por: Morinaga, Takao, et al.
Publicado: (2017)

Interferon-β Produces Synergistic Combinatory Anti-Tumor Effects with Cisplatin or Pemetrexed on Mesothelioma Cells
por: Li, Quanhai, et al.
Publicado: (2013)

Heat shock protein 90 inhibitors augment endogenous wild-type p53 expression but down-regulate the adenovirally-induced expression by inhibiting a proteasome activity
por: Chai, Kuan, et al.
Publicado: (2018)

Sensitivity of Commercially Available Influenza Rapid Diagnostic Tests in the 2018–2019 Influenza Season
por: Sakai-Tagawa, Yuko, et al.
Publicado: (2019)

Comparative In Vitro Dissolution of Two Commercially Available Er-Zhi-Wan Herbal Medicinal Products
por: Wang, M., et al.
Publicado: (2015)

Investigating the physical stability of repackaged medicines stored into commercially available multicompartment compliance aids (MCAs)
por: Raimi‐Abraham, Bahijja Tolulope, et al.
Publicado: (2017)

Regulatory requirements and labeling of commercially available prescription (oral) medicines in Sri Lanka: there is room for improvement
por: Jayasinghe, Manori, et al.
Publicado: (2022)

Availability, prices and affordability of essential medicines in Zhejiang Province, China
por: Dong, Zuojun, et al.
Publicado: (2020)

Combinatory cytotoxic effects produced by E1B-55kDa-deleted adenoviruses and chemotherapeutic agents are dependent on the agents in esophageal carcinoma
por: Ma, G, et al.
Publicado: (2010)

Price, availability and affordability of medicines
por: Mhlanga, Brenda S., et al.
Publicado: (2014)

Availability and affordability of medicines for children
por: Kazaryan, Irina, et al.
Publicado: (2015)

Commercially available accelerators
por: Barbalat, Oscar
Publicado: (1996)

The availability of six tracer medicines in private medicine outlets in Uganda
por: Birabwa, Catherine, et al.
Publicado: (2014)

Kampo Medicines for Frailty in Locomotor Disease
por: Nakae, Hajime, et al.
Publicado: (2018)

Towards Commercial Production of Sponge Medicines
por: Koopmans, Marieke, et al.
Publicado: (2009)

A survey of the availability, prices and affordability of essential medicines in Jiangsu Province, China
por: Xi, Xiaoyu, et al.
Publicado: (2015)

Reactivity and sensitivity of commercially available influenza rapid diagnostic tests in Japan
por: Sakai-Tagawa, Yuko, et al.
Publicado: (2017)

The commercialization of traditional medicine in modern Cambodia
por: Ros, Bandeth, et al.
Publicado: (2018)

Toward a logical integrative medicine: beyond data accumulation
por: Chi, Gyoo Yong
Publicado: (2020)

Prices, availability and affordability of medicines in Rwanda
por: Bizimana, Thomas, et al.
Publicado: (2020)

Field Validation of Commercially Available Food Retailer Data in the Netherlands
por: Canalia, Cesare, et al.
Publicado: (2020)

Essential Medicines Are More Available than Other Medicines around the Globe
por: Bazargani, Yaser T., et al.
Publicado: (2014)

Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces
por: Chen, Wen, et al.
Publicado: (2010)

Measuring Access to Medicines: A Survey of Prices, Availability and Affordability in Shaanxi Province of China
por: Jiang, Minghuan, et al.
Publicado: (2013)

Medicinal and commercial uses of ostrich products in Tanzania
por: Magige, Flora, et al.
Publicado: (2017)

Commercialism in Medicine; the Pernicious Multiplying of Medical Schools
Publicado: (1902)

Cannot write session to /tmp/vufind_sessions/sess_c9m9gq5d598dvtfk8v8al2l6nm